From green electricity tariffs to car sharing schemes, many sustainable products and services are being brought to market by start-ups. However, there has been relatively little research into how and why individuals take this step and whether their start-ups become a success. Fourteen European institutes coordinated by the Technical Univ. of Munich will be investigating this trend to see what potential it holds for a sustainable economy.
The solar panel installer SolarCity is beginning to address one of solar power's big drawbacks:...
Dow Chemical is looking to separate about 40 manufacturing plants from its business as it...
Bruker Corp. has announced that it has been...
The European Commission has approved the pending acquisition of Life Technologies Corp. by Thermo Fisher Scientific, which has committed to divest its cell culture (sera and media), gene modulation and magnetic beads businesses to expedite the approval. Combined, these businesses had 2012 revenue of approximately $225 million.
A federal judge on Thursday tossed out a class-action lawsuit brought by authors against Google Inc., clearing the way for the Internet giant to create the world's largest digital library. Google already has scanned more than 20 million books for the project. The Authors Guild, which brought the suit, was seeking $750 for each copyrighted book that was copied.
Drugmaker Eli Lilly and Co. plans to spend $715 million to bulk up its manufacturing in a key product line, insulin production. The Indianapolis company said it will spend $350 million to expand its insulin cartridge manufacturing in China, another $120 million for a similar improvement in France and $245 million to boost manufacturing capacity in Puerto Rico and Indianapolis.
The Wyss Institute for Biologically Inspired Engineering at Harvard Univ. and AstraZeneca have announced a collaboration that will leverage the Institute's organs-on-chips technologies to better predict safety of drugs in humans. Human organs-on-chips are composed of a clear, flexible polymer about the size of a computer memory stick, and contain hollow microfluidic channels lined by living human cells.
Any medical device implanted in the body attracts bacteria to its surface, causing infections and thrombosis that lead to many deaths annually. Devices can be coated with antibiotics and blood thinners, but these eventually dissolve, limiting their longevity and effectiveness. Now, Semprus BioSciences is developing a novel biomaterial for implanted medical devices that barricades these troublesome microbes from the device’s surface.
Bridging the gap between research institutes and enterprise is central to advance innovation and competitiveness in Europe, argue European Union (EU) officials and industry leaders. But how to get these separate orbiting planets acquainted with one another was the subject of heated debate at the 5th European Innovation Summit, held in Brussels.
Dow Chemical Co. is selling its global polypropylene licensing and catalysts business to W.R. Grace & Co. for $500 million. The sale includes Dow Chemical's polypropylene catalysts manufacturing plant in Norco, La., and customer contracts, licenses, intellectual property and inventory.
Gilead Sciences said Wednesday it stopped a late-stage clinical trial of a cancer treatment because it was clear the drug was working. Gilead was studying idelalisib as a treatment for chronic lymphocytic leukemia. The company said an early analysis of data from the study showed that patients who were treated with idelalisib had a longer time before the resumption of disease progression or death.
As the government's partial shutdown enters a second day, most companies across the country are doing business as usual. Yet concern is rising that a prolonged shutdown would cause some work at private companies to dry up and consumers to lose faith in the U.S. economy.
In the 1980s and 1990s, hydroelectric development stagnated as environmental groups lobbied against it and a long regulatory process required years of environmental study. But for the first time in decades, power companies are proposing new projects to take advantage of government financial incentives, policies that promote renewable energy over fossil fuels and efforts to streamline the permit process.
Poor research data can lead to mistakes in equipment selection, over-design of industrial plant components, difficulty simulating and discovering new processes, and poor regulatory decisions. However, traditional peer review is not enough to ensure data quality amid the recent boom in scientific research findings, according to results of a 10-year collaboration between NIST and five technical journals.
The U.S. Environmental Protection Agency (EPA) has launched a web-based tool, called ChemView, to significantly improve access to chemical specific regulatory information developed by EPA and data submitted under the Toxic Substances Control Act. The tool displays key health and safety data in an online format that allows comparison of chemicals by use and by health or environmental effects.
The U.S. National Science Foundation and U.K. Research Councils have entered into a new agreement designed to help support international research partnerships between the two nations. This new, two-way, lead-agency agreement enables a simplified and flexible process for researchers wishing to apply for U.S.-U.K. collaborative research funding, using the same systems and processes within the respective funding agencies.
Farmers who grow corn and soybeans can take advantage of government price support programs and crop insurance, but similar programs are not available for those who grow biomass crops. A new study recommends a framework for contracts between growers and biorefineries to help spell out expectations and designate who will assume the risks and costs.
Plaintiffs' attorneys who brokered a multibillion-dollar settlement with BP following the company's 2010 Gulf oil spill have asked a federal appeals court to uphold a judge's approval of the deal. Only a "paltry few objectors" have raised the "narrowest of concerns" about the settlement that U.S. District Judge Carl Barbier approved in December 2012, private lawyers said in a filing Tuesday with the 5th U.S. Circuit Court of Appeals.
Accelrys Inc. has announced that it has acquired ChemSW Inc., an environmental health and safety (EH&S) compliance solutions provider. This acquisition furthers Accelrys’ strategy by providing solutions for managing and tracking the source, use and disposal of chemicals along the entire lab-to-plant value chain.
The Department of Systems Biology at the Technical University of Denmark (DTU) have formed a collaboration with Thermo Fisher Scientific to pursue breakthroughs in the understanding of how cellular protein networks drive important diseases. Under the collaboration, Thermo Fisher will provide early access to new technology and designs, and DTU proteomics scientists will provide feedback and collaborate on new applications.
Microsoft Corp. is buying Nokia Corp.'s devices and services business, and getting access to the company's patents, for a total of $7.2 billion in an effort to expand its share of the smartphone market, the companies announced. Microsoft will pay $5 billion for the Nokia unit that makes mobile phones, including its line of Lumia smartphones that run Windows Phone software.
The law that has helped medical discoveries make the leap from university labs to the marketplace for more than 30 years needs revising, according to Univ. of Michigan doctor has taken another look at the history of Bayh-Dole. He says that the Supreme Court ruling on gene patenting, and modern risks raised by industry/academic interaction, signal a need for change.
Bottles of Tylenol sold in the U.S. will soon bear red warnings alerting users to the potentially fatal risks of taking too much of the popular pain reliever. The unusual step, disclosed by the company that makes Tylenol, comes amid a growing number of lawsuits and pressure from the federal government that could have widespread ramifications for a medicine taken by millions of people every day.
For the first time, Ford is making its Fusion sedan in the U.S. The company's Flat Rock, Michigan, plant began making the Fusion on Thursday. The plant, which is about 25 miles (40 km) south of Detroit, made the Ford Mustang sports car before getting a second shift of 1,400 workers to make the Fusion. The plant now has 3,100 workers.
A new Department of Energy study conducted by the National Renewable Energy Laboratory indicates that by 2025 wind and solar power electricity generation in the western U.S. could become cost-competitive without federal subsidies, if new renewable energy development occurs in the most productive locations. The report is now available.
As several new private ventures to take people on trips to space come closer to becoming reality, California lawmakers are racing other states to woo the new space companies with cushy incentives. They are debating a bill now in Sacramento that would insulate manufacturers of spaceships and parts suppliers from liability should travelers get injured or killed on a voyage, except in cases such as gross negligence or intentional wrongdoing.
Onyx Pharmaceuticals and Bayer said Tuesday that regulators will conduct a faster review of their pill Nexavar as a treatment for thyroid cancer. The U.S. Food and Drug Administration (FDA) is reviewing Nexavar as a treatment for locally advanced or metastatic thyroid cancer that doesn't respond to treatment with radioactive iodine. The companies said the FDA expects to complete its review by Dec. 25. to.
First Solar Inc. said that it sold a collection of solar projects in Canada totaling 50 MW to an investment partnership led by GE Energy's financial services arm. Financial terms were not disclosed. First Solar has completed construction of the power plants, which are all located in Ontario, and the plants providing power to the grid. First Solar will provide operations and maintenance services under long-term contracts.
- Page 1